Sebba, Anthony <br/><br/>
Osteoporosis: how long should we treat?  [electronic resource] 

 -  Current opinion in endocrinology, diabetes, and obesity  Dec 2008 
 - 502-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1752-2978 
<br/><br/><label>Standard No.: </label>10.1097/MED.0b013e328317ca83  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Clinical Protocols--standards<br/>Denosumab<br/>Diphosphonates--administration & dosage<br/>Hip Fractures--prevention & control<br/>Humans<br/>Osteoporosis--drug therapy<br/>RANK Ligand--administration & dosage<br/>Spinal Fractures--prevention & control<br/>Withholding Treatment--standards